LINC02322

Across TCGA pan-cancer cohorts, LINC02322 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02322 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02322 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02322 expression acts as an unfavorable survival marker, although some lineages such as PAAD and BRCA show a favorable association.

COAD, THCA, and UVM are the cancer types where LINC02322 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.782	0.888	.001	114	view →
THCA	DFS	Tertile	All	0.709	0.866	<.001	103	view →
UVM	DFS	Tertile	III,IV	0.327	0.736	.005	61	view →
LGG	DFS	Tertile	All	0.621	0.776	<.001	34	view →
ACC	OS	Tertile	III,IV	0.425	0.862	<.001	30	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	24	view →
SKCM	DFS	Quartile	II,III,IV	0.501	0.768	.002	19	view →
PAAD	DFS	Quartile	All	0.508	0.210	.006	15	view →
BRCA	DFS	Median	III,IV	0.927	0.840	.005	14	view →
TGCT	DFS	Quartile	II,III,IV	0.684	1.000	.040	6	view →
SARC	DFS	Tertile	All	0.342	0.520	.045	6	view →
ESCA	OS	Quartile	III,IV	0.698	0.355	.022	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02322–COAD (OS)

Open the COAD breakdown →